← Open Payments lookup

RABIA JAFRI: Open Payments

NPI 1932342482 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,611 in 78 payments from 17 companies in 2025. Trend: 2023 $789 · 2024 $807 · 2025 $1,611

Food & beverage: $1,611
CompanyPaymentsAmount
ABBVIE INC.24$346
Otsuka America Pharmaceutical, Inc.8$195
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$181
E.R. Squibb & Sons, L.L.C.9$180
Alkermes, Inc.8$175
Vanda Pharmaceuticals Inc.5$95
Takeda Pharmaceuticals U.S.A., Inc.4$93
Supernus Pharmaceuticals, Inc.3$79
Axsome Therapeutics, Inc.3$51
Neurocrine BioSciences, Inc.2$44

Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, ARISTADA, FANAPT, TRINTELLIX, Qelbree.

Industry payments across VA — which companies pay providers there.